Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 9,952 shares at $10.73 ($107K) on 2023-08-18, disclosed to the SEC on 2023-08-21.
Open-market sale of $107k KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.73 | 4,976 | $53K | 50.0% |
| 2 | $10.73 | 4,976 | $53K | 50.0% |
| Total | $10.73 avg | 9,952 | $107K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |